ABUJA, Nigeria — Africa is seeing a rapid increase in mpox cases with nearly 4,000 reported in the past week, the continent’s public health body said Tuesday as it repeated a plea for long-awaited vaccines whose arrival this week in the most affected country, Congo, has been delayed.
Eighty-one deaths from mpox were reported in Africa in the past week, bringing the total cases and deaths to 22,863 and 622, respectively, Dr. Jean Kaseya, head of the Africa Centers for Disease Control and Prevention, told an online briefing.

Christophe Chavilinga, suffering from mpox, waits for treatment at a clinic in Munigi, Congo, on Aug. 16. Moses Sawasawa/Associated Press
About 380,000 doses of mpox vaccines have been promised by Western partners such as the European Union and the United States, he said. That’s less than 15% of the doses authorities have said are needed to end the mpox outbreaks in Congo, the epicenter of the global health emergency.
Following mpox outbreaks outside the African continent in 2022, wealthy countries quickly responded with vaccines and treatments from their stockpiles. However, only a few doses have reached Africa despite pleas from its governments.
At the earliest, the first batch of vaccine doses promised to support the new outbreaks in Congo will arrive on Sept. 1 after delays caused by documentation and emergency authorization issues, Kaseya said.
The batch would include 50,000 doses promised by the U.S. government and 15,000 from vaccines alliance GAVI, said Dr. Ngashi Ngongo, the Africa CDC incidents manager on mpox.
“It is just a matter of now waiting on the U.S. government on the transfer of those vaccines,” Ngongo said.
Congo has also requested at least 2 million doses from Japan of vaccines that are particularly effective in protecting children, he said, with negotiations “quite advanced.”
The new mpox variant first detected in Congo and blamed for the ongoing outbreaks is already triggering “significant” community-level transmission elsewhere, Ngongo said.
For example, in neighboring Burundi, nearly 800 mpox cases have been recorded in the last month, he said.
The U.S. on Tuesday donated 10,000 doses of mpox vaccines to Nigeria, where the disease has been common. It is the first known donation to Africa since the current outbreaks. Nigeria has recorded 40 mpox cases this year, according to Nigeria’s CDC.
The Africa CDC said it is working on a unified response plan for the outbreaks which will be presented to African heads of state for consideration at a meeting in September.
So far, African countries are promoting health measures and hygiene practices that would slow the spread of the mpox virus, Kaseya said.
Experts, however, have said such measures are difficult to enforce in Congo, where millions fleeing violence are crammed in displaced camps amid a decadelong humanitarian crisis.
“Humanitarian actors are struggling to control the outbreak due to insufficient resources,” said Heather Kerr, the International Rescue Committee country director in Congo, adding that children are especially vulnerable.
Send questions/comments to the editors.
Join the Conversation
We believe it’s important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It’s a form of open discourse that can be useful to our community, public officials, journalists and others. Read more...
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
For those stories that we do enable discussion, our system may hold up comments pending the approval of a moderator for several reasons, including possible violation of our guidelines. As the Maine Trust’s digital team reviews these comments, we ask for patience.
Comments are managed by our staff during regular business hours Monday through Friday and limited hours on Saturday and Sunday. Comments held for moderation outside of those hours may take longer to approve.
By joining the conversation, you are agreeing to our commenting policy and terms of use. More information is found on our FAQs.
You can modify your screen name here.
Show less
Join the Conversation
Please sign into your Press Herald account to participate in conversations below. If you do not have an account, you can register or subscribe. Questions? Please see our FAQs.